REsPonse to Interferon-Alpha in InterfeRon-β Neutralizing Antibody Positive Multiple Sclerosis Patients
Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine if Interferon-alfa is effective and safe in multiple
sclerosis patients who developed neutralizing antibodies for Interferon-beta.